Detalhe da pesquisa
1.
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Gynecol Oncol
; 134(3): 599-606, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995579
2.
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proc Natl Acad Sci U S A
; 106(12): 4834-9, 2009 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19261849
3.
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Br J Cancer
; 98(10): 1662-9, 2008 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18475299